Roger Sun has over 25 years of experience in business development, venture development and investment, corporate strategy and planning, alliance/partnership management, portfolio management, new product development, marketing strategy and clinical practice from various roles in biotechnology industry. Dr. Sun is the CEO and founder of Simedice Biotechnologies, Inc. which develops, manufactures, and markets high-end hydrophobic intraocular lens products including trifocal lens, trifocal toric lens and EDOF lens to treat global cataract patients.
This person is not in the org chart
This person is not in any offices
ArcScan
High Frequency Robotic Ultrasound. Gold Standard in Ophthalmic Imaging. Improving surgical planning and imaging for ICL sizing, early detection keratoconus and glaucoma, pre and post op IOL